SDGR

Schrödinger develops a physics-based computational software platform used for drug discovery and development, which it licenses to pharmaceutical and biotech customers and also applies to its own proprietary drug discovery programs. The platform is designed to predict molecular behavior and is being expanded to assess toxicology risk early in drug discovery. Schrödinger is in the preclinical and clinical trial stages for its proprietary drug candidates and operates drug discovery collaborations with partners including Novartis.

Pipeline

Catalyst Calendar